ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 783

$961K Total Retail Price of All Prescriptions

Rank: 53 out of 783

589 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 589 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 13,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 600 507 S3 1 2
LEVOTHYROXINE SODIUM 528 450 2 1
SIMVASTATIN 470 412 3 3
AMLODIPINE BESYLATE 466 427 4 5
OMEPRAZOLE 449 392 5 6
FUROSEMIDE 437 359 6 7
LISINOPRIL 338 315 7 4
GABAPENTIN 325 279 8 15
CITALOPRAM HBR 274 238 9 19
METFORMIN HCL 256 198 10 8
WARFARIN SODIUM 209 179 11 10
TRAZODONE HCL 194 130 12 39
METOPROLOL SUCCINATE 190 171 13 13
CLOPIDOGREL 184 174 14 29
ZOLPIDEM TARTRATE 180 135 15 23
HYDROCHLOROTHIAZIDE 176 165 16 12
POTASSIUM CHLORIDE 165 123 17 16
PRAVASTATIN SODIUM 162 155 18 14
DONEPEZIL HCL 160 147 19 24
PLAVIX 154 147 20 51
NEXIUM 151 118 21 28
ATENOLOL 151 122 21 17
TAMSULOSIN HCL 144 123 23 26
METOPROLOL TARTRATE 142 137 24 9
ESCITALOPRAM OXALATE 138 102 25 54
PANTOPRAZOLE SODIUM 134 118 26 30
SERTRALINE HCL 133 112 27 22
MELOXICAM 132 117 28 37
LANTUS 127 106 29 38
ALLOPURINOL 125 108 30 31
CYMBALTA 124 87 31 35
ATORVASTATIN CALCIUM 123 103 32 11
TRAMADOL HCL 121 114 33 20
ROPINIROLE HCL 117 77 34 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 105 35 33
OXYCODONE HCL-ACETAMINOPHEN 113 54 S2 36 86
ALENDRONATE SODIUM 101 86 37 25
GLIMEPIRIDE 100 84 38 34
MIRTAZAPINE 96 96 39 52
SYNTHROID 94 91 40 47
DIOVAN 92 91 41 49
VENLAFAXINE HCL ER 90 62 42 100
KLOR-CON M10 87 87 43 137
JANUVIA 85 66 44 73
CARVEDILOL 84 79 45 21
RANITIDINE HCL 84 67 45 44
FLUOXETINE HCL 84 63 45 45
SINGULAIR 82 76 48 90
RISPERIDONE 76 71 49 67
HUMALOG 75 54 50 101
AZITHROMYCIN 74 70 51 41
PREDNISONE 73 58 52 36
DIVALPROEX SODIUM 72 72 53 72
POLYETHYLENE GLYCOL 3350 72 71 53 43
ALBUTEROL SULFATE 71 71 55 136
NAMENDA 70 60 56 32
ADVAIR DISKUS 69 61 57 50
DOXAZOSIN MESYLATE 67 55 58 87
CELEBREX 67 63 58 93
PROAIR HFA 64 48 60 56
MONTELUKAST SODIUM 63 59 61 160
OXYCODONE HCL 61 27 S2 62 123
ISOSORBIDE MONONITRATE ER 61 61 62 40
AMOX TR-POTASSIUM CLAVULANATE 61 46 62 128
BENAZEPRIL HCL 60 59 65 85
CLONIDINE HCL 60 60 65 60
LOSARTAN-HYDROCHLOROTHIAZIDE 59 47 67 53
INSULIN SYRINGE 59 48 67 82
ZETIA 59 56 67 80
LEVOFLOXACIN 58 48 70 75
NOVOLOG FLEXPEN 57 50 71 142
DICLOFENAC SODIUM 57 50 71 139
BUSPIRONE HCL 56 42 73 124
KLOR-CON 10 55 34 74 102
FENTANYL 55 29 S2 74 65
VESICARE 53 53 76 188
COMBIVENT 53 45 76 120
BUPROPION HCL SR 53 43 76 166
LOSARTAN POTASSIUM 51 51 79 18
ABILIFY 51 41 79 148
PHENYTOIN SODIUM EXTENDED 51 37 79 141
FAMOTIDINE 51 45 79 55
SPIRIVA 51 51 79 59
ESTRADIOL 51 36 R 79 204
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.